Nicholas J Short Selected Research

Nicholas J Short Research Topics

Disease

48	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 11/2015
38	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2022 - 12/2016
32	Philadelphia Chromosome 09/2022 - 12/2016
10	Leukemia 11/2022 - 12/2017
9	Neoplasms (Cancer) 12/2020 - 01/2014
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2022 - 11/2015
7	Residual Neoplasm 01/2020 - 01/2016
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 11/2017
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2021 - 11/2015
4	Infections 01/2020 - 01/2018
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 03/2017
3	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2016
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2021 - 01/2017
3	Pathologic Complete Response 07/2020 - 12/2018
2	Hyperbilirubinemia 01/2022 - 11/2017
2	Central Nervous System Diseases (CNS Diseases) 01/2022 - 10/2021
2	Blast Crisis (Blast Phase) 01/2021 - 12/2017
2	Cytopenia 01/2021 - 01/2020
2	Disease Progression 01/2021 - 03/2018
2	Hypertension (High Blood Pressure) 12/2020 - 12/2018
2	Exanthema (Rash) 12/2018 - 11/2017
2	Dehydration (Water Stress) 11/2008 - 06/2007
1	Frailty 07/2022
1	Hyperuricemia 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Uterine Hemorrhage (Uterine Bleeding) 01/2021
1	Juvenile Myelomonocytic Leukemia 01/2021
1	Eosinophilia 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Neutropenia 01/2021
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2021
1	Osteoporosis 12/2020
1	Metabolic Bone Diseases (Osteopenia) 12/2020
1	Sepsis (Septicemia) 07/2020
1	Heart Arrest (Cardiac Arrest) 07/2020
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020
1	Thymoma (Thymic Carcinoma) 06/2019
1	Aplastic Anemia (Anemia, Hypoplastic) 06/2019
1	Acquired amegakaryocytic thrombocytopenia 06/2019

Drug/Important Bio-Agent (IBA)

23	venetoclaxIBA 11/2022 - 01/2020
17	Tyrosine Kinase InhibitorsIBA 09/2022 - 01/2016
11	Decitabine FDA Link 12/2021 - 01/2017
10	blinatumomabIBA 09/2022 - 12/2017
9	ponatinibIBA 05/2022 - 12/2016
7	Vincristine (Oncovin)FDA LinkGeneric 10/2021 - 01/2016
6	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2022 - 01/2016
6	Dasatinib (BMS 354825)FDA Link 05/2022 - 12/2016
6	Inotuzumab OzogamicinIBA 01/2022 - 01/2018
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 11/2015
5	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021 - 01/2016
5	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 01/2016
4	fms-Like Tyrosine Kinase 3IBA 01/2022 - 01/2019
4	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 01/2017
3	Rituximab (Mabthera)FDA Link 10/2021 - 11/2015
3	Transaminases (Aminotransferases)IBA 12/2018 - 11/2017
3	fludarabineIBA 01/2018 - 11/2015
2	AnthracyclinesIBA 05/2022 - 01/2016
2	bcr-abl Fusion ProteinsIBA 01/2022 - 01/2020
2	CreatinineIBA 01/2022 - 12/2018
2	ofatumumab FDA Link 01/2021 - 07/2020
2	ibrutinibIBA 01/2020 - 09/2018
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2018 - 11/2017
2	Clofarabine (Clolar)FDA Link 01/2018 - 11/2017
2	Purine NucleosidesIBA 01/2018 - 11/2017
1	Cladribine FDA LinkGeneric 11/2022
1	purineIBA 05/2022
1	trametinibIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2022
1	enasidenibIBA 01/2022
1	gilteritinibIBA 12/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	AzolesIBA 01/2021
1	Core Binding Factors (Core-Binding Factor)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021
1	nelarabine (506U78)FDA Link 01/2021
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	MethyltransferasesIBA 01/2021
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Leuprolide (Lupron)FDA LinkGeneric 01/2021
1	NucleophosminIBA 12/2020
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2020
1	ruxolitinibIBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Gemtuzumab (Mylotarg)FDA Link 01/2020
1	CR 6IBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2019

Therapy/Procedure

37	Drug Therapy (Chemotherapy) 11/2022 - 01/2016
29	Therapeutics 09/2022 - 11/2015
5	Stem Cell Transplantation 07/2020 - 01/2016
4	Induction Chemotherapy 01/2022 - 01/2016
3	Salvage Therapy 01/2021 - 01/2020
2	Immunotherapy 01/2022 - 01/2020
2	Consolidation Chemotherapy 01/2020 - 01/2018
1	Radiotherapy 01/2020